Back
Acasti Pharma Vs. Edesa Biotech Industry Stock Comparison
Buy
53
ACST
Acasti Pharma
Last Price:
2.90
Seasonality Move:
-4%
Sell
36
EDSA
Edesa Biotech
Last Price:
4.25
Seasonality Move:
20.85%
Buy
53
Acasti Pharma (ACST)
is a Buy
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.92. The Score for ACST is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ACST is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Edesa Biotech (EDSA)
is a Sell
Is Edesa Biotech a Buy, Sell or Hold?
- The current Edesa Biotech [EDSA] share price is $4.28. The Score for EDSA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- EDSA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing buying pressure, which is a positive indicator for future bullish movement.
EDSA Stock Price Chart
What is Edesa Biotech's stock price today?
-
The Edesa Biotech share price today is $4.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDSA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 44.16 | Sell |
| Chaikin Money Flow: | 58405 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.79 - 3.23) | Sell |
| Bollinger Bands (100): | (2.77 - 3.39) | Sell |
EDSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 45.16 | Sell |
| Chaikin Money Flow: | 5946 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.28 - 4.54) | Sell |
| Bollinger Bands (100): | (4.23 - 4.85) | Sell |
ACST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.11 | Sell |
| 20-day SMA: | 3.1 | Sell |
| 50-day SMA: | 2.92 | Buy |
| 200-day SMA: | 2.74 | Buy |
| 8-day EMA: | 3.06 | Sell |
| 20-day EMA: | 3.06 | Sell |
| 50-day EMA: | 3.01 | Sell |
| 200-day EMA: | 2.93 | Sell |
EDSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.3 | Sell |
| 20-day SMA: | 4.42 | Sell |
| 50-day SMA: | 4.45 | Sell |
| 200-day SMA: | 4.39 | Sell |
| 8-day EMA: | 4.32 | Sell |
| 20-day EMA: | 4.38 | Sell |
| 50-day EMA: | 4.43 | Sell |
| 200-day EMA: | 4.94 | Sell |
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.10 per share, an increase this year of $1.16 per share, and an increase next year of $0.35 per share.
Edesa Biotech Earnings Growth & EDSA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Acasti Pharma Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Edesa Biotech Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||